Consent of Independent Registered Public Accounting Firm
Miragen Therapeutics, Inc. (formerly Signal Genetics, Inc.)
We hereby consent to the incorporation by reference in the Registration Statements on
Form S-3 (Nos. 333-205620 and 333-205618) and Form S-8 (Nos. 333-197316, 333-213142 and 333-216112) of Miragen Therapeutics, Inc.
(formerly Signal Genetics, Inc.) of our report dated March 24, 2017, relating to the consolidated financial statements which appear
in this Form 10-K.
/s/ BDO USA, LLP
San Diego, California
March 24, 2017